Skip to Content

Label Changes for:

Aceon (perindopril erbumine) Tablets

March 2015

Changes have been made to the PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)  

March 2015


Dual Blockade of the Renin-Angiotensin System (RAS)
  • added...Most patients receiving the combination of two RAS inhibitors do not obtain any additional benefit compared to monotherapy. In general, avoid combined use of RAS inhibitors.


February 2013


  • Do not co-administer aliskiren with Aceon in patients with diabetes